These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14273313)

  • 1. IN VITRO SUSCEPTIBILITY OF GROUP A BETA HEMOLYTIC STREPTOCOCCI TO 18 ANTIBIOTICS.
    EICKHOFF TC; FINLAND M; WILCOX C
    Am J Med Sci; 1965 Mar; 249():261-8. PubMed ID: 14273313
    [No Abstract]   [Full Text] [Related]  

  • 2. A NEW SELECTIVE BLOOD AGAR MEDIUM FOR STREPTOCOCCUS PYOGENES AND OTHER HAEMOLYTIC STREPTOCOCCI.
    LOWBURY EJ; KIDSON A; LILLY HA
    J Clin Pathol; 1964 May; 17(3):231-5. PubMed ID: 14159449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAFCILLIN: A COMPARATIVE IN-VITRO TRIAL.
    LANE WR
    Med J Aust; 1964 Sep; 2():499-501. PubMed ID: 14205712
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotics susceptibility of Streptococcus and Enterococcus: data of Onerba network].
    Vachée A; Varon E; Jouy E; Meunier D;
    Pathol Biol (Paris); 2009 May; 57(3):240-4. PubMed ID: 18343047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A medium containing nucleic acid, maltose, and antibiotics for the isolation of group A hemolytic streptococci.
    ROANTREE RJ; RANTZ LA; HAINES E
    J Lab Clin Med; 1958 Sep; 52(3):496-500. PubMed ID: 13575942
    [No Abstract]   [Full Text] [Related]  

  • 7. A COMPARISON OF ANTHELMINTIC AND ANTIBACTERIAL ACTIVITY OF SOME PHLOROGLUCINOL DERIVATIVES.
    BOWDEN K; ROSS WJ
    J Pharm Pharmacol; 1965 Apr; 17():239-42. PubMed ID: 14327713
    [No Abstract]   [Full Text] [Related]  

  • 8. EXPERIMENTAL ANTICANCER STUDIES. XXI. EFFECT OF PENICILLIN TREATMENT OF HEMOLYTIC STREPTOCOCCUS ON ITS ANTICANCER ACTIVITY.
    KOSHIMURA S; SHIMIZU R; FUJIMURA A; OKAMOTO H
    Gan; 1964 Jun; 55():233-6. PubMed ID: 14188566
    [No Abstract]   [Full Text] [Related]  

  • 9. [CHEMICAL AND CHEMOTHERAPEUTICAL STUDIES ON THE FURAN DERIVATIVES. 36. IN VITRO AND IN VIVO ANTIBACTERIAL ACTIVITY OF NITROFURANQUINOLINE DERIVATIVES].
    MIURA K; IKEDA M; OOHAHI T; IGARASHI Y; OKADA I; SHIKIMI T; ISHII S
    Yakugaku Zasshi; 1965 Apr; 85():289-98. PubMed ID: 14322601
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibiotic susceptibility of group A beta hemolytic Streptococcus].
    Cengiz AT; Kiyan M; Ciftçioğlu N
    Mikrobiyol Bul; 1989 Apr; 23(2):163-73. PubMed ID: 2696867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity of groups A, B and C beta hemolytic streptococci to antibiotics].
    González-Lama Z; González JJ; Tejedor MT; Lupiola P
    Rev Esp Quimioter; 1999 Sep; 12(3):215-9. PubMed ID: 10878511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-AMINODESACETOXYCEPHALOSPORANIC ACID AND ITS DERIVATIVES.
    STEDMAN RJ; SWERED K; HOOVER JR
    J Med Chem; 1964 Jan; 7():117-9. PubMed ID: 14186012
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ; Toleman MA; Walsh TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Jun; 55(2):119-27. PubMed ID: 16530373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MODIFIED HEMOLYTIC PROPERTIES OF STREPTOCOCCUS SCARLATINAE UNDER THE INFLUENCE OF PENICILLIN AND STREPTOMYCIN].
    PILIPENKO AN
    Antibiotiki; 1964 Aug; 9():748-50. PubMed ID: 14239568
    [No Abstract]   [Full Text] [Related]  

  • 15. EFFECT OF CYSTEINE ON FORMATION OF STREPTOLYSIN S BY GROUP A STREPTOCOCCI.
    GINSBURG I; BENTWICH Z
    Proc Soc Exp Biol Med; 1964 Dec; 117():670-5. PubMed ID: 14244921
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility of hemolytic streptococci, other than those of group D, to eleven antibiotics in vitro.
    JONES WF; FELDMAN HA; FINLAND M
    Am J Clin Pathol; 1957 Feb; 27(2):159-69. PubMed ID: 13410849
    [No Abstract]   [Full Text] [Related]  

  • 17. [STUDY IN VITRO OF THE ACTIVITY OF LINCOMYCIN: PRACTICAL CONCLUSIONS].
    FONTAINE J; LEDUC A
    Union Med Can; 1965 Mar; 94():349-51. PubMed ID: 14331401
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibiotic sensitivity of strains of group A beta-hemolytic streptococci isolated recently].
    Alós JI; González-Palacios R; Cuadros JA; Escobar JC
    Med Clin (Barc); 1990 Jan; 94(1):12-4. PubMed ID: 2186225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current antibiotic susceptibility of group A beta-hemolytic streptococci.
    Bourbeau P; Campos JM
    J Infect Dis; 1982 Jun; 145(6):916. PubMed ID: 7045252
    [No Abstract]   [Full Text] [Related]  

  • 20. [ANTIBIOTIC ACTIVITY OF A NEW QUINOLINE DERIVATIVE (5-NITRO8-HYDROXYQUINOLINE)].
    DESVIGNES A; LEGUEN P
    Ann Pharm Fr; 1963 Dec; 21():803-8. PubMed ID: 14116184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.